目的：本研究探討基隆市30歲以上婦女定期接受子宮頸抹片篩檢與「基隆市社區闔家歡健康篩檢」經驗之關係，並針對有參加「基隆市社區闔家歡健康篩檢」者分析定期接受子宮頸抹片篩檢的因素。
材料與方法：以民國89年到民國96年基隆市闔家歡健康篩檢（以下簡稱KCIS）資料為主，並連結國民健康局子宮頸抹片篩檢名冊中，30歲以上婦女接受子宮頸抹片篩檢的紀錄，觀察接受子宮頸抹片篩檢的情形。先分析國民健康局子宮頸抹片篩檢名冊中90382位婦女的KCIS經驗與接受子宮頸抹片篩檢之關係，再針對曾經接受KCIS的23533位婦女，探討社會人口學變項與定期接受子宮頸抹片篩檢之關係，最後探討18574位資料完整的婦女其影響疾病史及健康行為與定期子宮頸抹片篩檢行為的因素為何。本研究以SAS 9.1版套裝統計軟體進行描述性統計、雙變項分析及邏輯斯回歸分析。
研究結果：1.以基隆市子宮頸抹片篩檢名冊中，曾經做過子宮頸抹片篩檢的婦女為對象分析，結果發現曾接受KCIS篩檢的婦女定期接受子宮頸抹片篩檢的百分比較未曾接受KCIS的婦女高。2.以有接受KCIS的婦女為對象分析，與定期抹片篩檢相關之社會人口學變項，教育程度較高者、有偶的婦女較會定期做子宮頸抹片篩檢；但設籍七堵區的婦女較不會定期做子宮頸抹片篩檢。3. 以有接受KCIS的民眾、在疾病史與健康行為資料中無遺漏值的婦女為對象分析，發現有家族癌症病史及有家族慢性病史的婦女較會定期做子宮頸抹片篩檢，但有個人慢性病史的婦女較不會定期去做子宮頸抹片篩檢；在健康行為中，曾經有吸菸習慣的婦女較不會定期做子宮頸抹片篩檢，有運動習慣的婦女較會定期去做子宮頸抹片篩檢。
結論與建議：本研究發現有接受KCIS的婦女，教育程度較高、有偶、有家族癌症病史、有家族慢性病使、無個人慢性病史、從未吸菸及有運動習慣者，較會定期去接受子宮頸抹片篩檢。若能提升KCIS的參與率，相信能有效提升婦女定期參加子宮頸抹片篩檢的行為；並針對未能定期參加子宮頸抹片篩檢的高危險群，提供相關的宣導策略，提升定期篩檢率。

Objectives: The purpose of this study was to analysis the relationship between regular papanicolaus (pap) smear screening and the experience of the "Keelung Community-based Integrated Screening" (KCIS) in Keelung City women over 30 years.

Methods: The data of this study were draw from 2000 to 2007 Keelung Community-based Integrated Screening (KCIS) and records of pap smear in the Bureau of Health Promotion. 90,382 records were included. The dependent variable was behavior of regular papanicolaus (pap) smear screening. The independents included social-demographic variables, family disease history, personal disease history, and health behaviors. The main statistic method was logistic regression, using SAS 9.1 version package.

Results: Women who had experience of KCIS had higher rate of regular pap smear screening than who had not. In KCIS participants, women who were higher levels education and have a spouse, had family disease history, never smoking, and exercise behavior more likely to have regular pap smear screening.

Conclusion: The study found that women who had experience of KCIS, highly educated, have a spouse, have a family disease history, have no individual history of chronic illness, never smoking and have exercise behavior were more likely to receive regular pap smear screening. Encourage women to participate KCIS may could effectively promote women to receive regularly pap smear screening in addition to health education and advocacy strategies.

目錄
第一章 前言………………………………………………………………………………………………1
第一節 研究動機……………………………………………………………………………….1
第二節 研究目的……………………………………………………………………………….3
第二章 文獻探討……………………………………………………………………………………...4
第一節 子宮頸癌以及子宮頸抹片篩檢………………………………………….4
第二節 影響婦女參加子宮頸抹片篩檢的相關因素……………………..7
第三節 影響婦女定期參加子宮頸抹片篩檢的相關因素…………..12
第四節 小結……………………………………………………………………………………..16
第三章 材料與方法………………………………………………………………………………..17
第一節 研究對象來源…………………………………………………………………….17
第二節 資料收集方法……………………………………………………………………..18
第三節 研究架構……………………………………………………………………………..24
第四節 變項定義……………………………………………………………………………..25
第五節 統計方法……………………………………………………………………………..27
第四章 結果……………………………………………………………………………………………28
第一節 KCIS經驗與子宮頸抹片篩檢行為間的關係………………..28
第二節 社會人口學變項與定期子宮頸抹片篩檢行為間的關係
……………………………………………………………………………………………..29
第三節 疾病史和健康行為與定期子宮頸抹片篩檢行為間的關係
…………………………………………………………………………………………….32
第五章 討論…………………………………………………………………………………………….37
第一節 KCIS經驗與定期子宮頸抹片篩檢行為的關係……………..37
第二節 定期子宮頸抹片篩檢之相關因素探討…………………………...38
第三節 研究對象的調整……………………………………………………………….41
第四節 研究限制……………………………………………………………………………..43
第六章 結論與建議………………………………………………………………………………..44
第一節 結論……………………………………………………………………………………44
第二節 建議……………………………………………………………………………………45
參考文獻……………………………………………………………………………………………………46

表目錄
表一 影響婦女參加子宮頸抹片篩檢的相關因素整理……………………..10
表二 影響婦女定期參加子宮頸抹片篩檢的相關因素整理……………..15
表三 民國89年至94年KCIS資料與國民健康局之民國89年至96年子宮頸抹片篩檢名冊連結結果………………………………………………19
表四 有KCIS經驗婦女之第一次篩檢結果與篩檢間隔之雙變項分析(N=43035) ……………………………………………………………………………………..23
表五 疾病史與健康行為中完整樣本與有遺漏值樣本之雙變項分析(N=23533) ……………………………………………………………………………………..23
表六 KCIS經驗與子宮頸抹片篩檢行為之雙變項分析(N=90382) …28
表七 子宮頸抹片篩檢行為與社會人口學變項之雙變項分析
(N=23533) ……………………………………………………………………………………..30
表八 定期篩檢者與不定期篩檢者之邏輯斯回歸分析(N=23533) …..31
表九 疾病史、健康行為與定期子宮頸抹片篩檢行為之雙變項分析(N=18574) ……………………………………………………………………………………..34
表十 定期篩檢者與不定期篩檢者疾病史及健康行為之邏輯斯回歸分析(N=18574) ……………………………………………………………………………..36

圖目錄
圖一 研究對象子宮頸抹片篩檢及KCIS經驗分組示意圖………………20
圖二 研究架構………………………………………………………………………………………..24

中文文獻
王本仁、黃心苑、周穎政、李丞華、張鴻仁：全民健保子宮頸抹片檢查受檢情形影響因數分析－個體時間序列資料之實證研究，1997~2000。台灣衛誌，2005；24(1)：33-42。
朱後穗：如何預防子宮頸癌。當代醫學，2000；27(11)：70-77。
行政院衛生署：衛生統計資訊網。http://www.doh.gov.tw/statistic/index.htm，2008。
行政院衛生署國民健康局：健康統計資訊。http://www.bhp.doh.gov.tw/BHPnet/Portal/Statistics.aspx，2008。
行政院衛生署國民健康局：婦癌防治─關心子宮頸癌。http://www.bhp.doh.gov.tw/bhpnet/portal/Them.aspx?No=200712250033，2008。
吳岱穎、郭冠良、陳建志、林光洋、黃惠娟：子宮頸癌的篩檢.。基層醫學，2004；19(12)：288-295。
李翠鳳、郭旭崧、陳錫中、陳天順、周碧瑟：金門縣婦女子宮頸防癌抹片檢查的影響因素。中華衛誌，1997；16(3)：198-210。
周碧瑟、賴明芸：各國子宮頸癌篩檢計畫之初探。公共衛生，1993；19(4)：384-392。
周碧瑟、賴明芸：各國子宮頸癌篩檢計畫之初探。公共衛生，1993；19(4)：384-392。
林惠賢、王琳華、劉淑敏、康啟杰：屏東地區婦女接受子宮頸抹片檢查之相關因素。台灣衛誌，2003；22(2)：127-133。
邱彥坤：子宮頸癌的病因與預防.。台灣醫界，1997；40(4)：25-28。
國家衛生研究院：子宮頸癌篩檢及治療共識。http://www.nhri.org.tw，2000。
許維邦：抹片和子宮頸癌.。基層醫學，1998；13(2)：34-36。
陳協勝、吳濟華、朱斌妤：婦女接受子宮頸抹片檢查行為意向模式之研究。中華心理衛生學刊，2002；15(3)：31-66。
陳慈怡、李嬿如、游山林、陳建仁、謝長堯、陳素秋：全民健保實施前後影響子宮頸抹片篩檢之因素及成果。臺灣衛誌，2005；24(5)：440-451。
陳錫中、周碧瑟：台灣鄉村婦女對「子宮頸防癌抹片檢查」的認知及參與之調查研究。中華衛誌，1995；14(6)：494-501。
曾志仁：子宮頸抹片檢查。中華民國婦產科醫學會通訊，1999；9：13-19。
黃月桂、葉明義、林勤豐：全民健康保險子宮頸抹片檢查之利用度研究。中華衛誌，1998；17(1)：28-35。
葉季森、周碧瑟：以健康信念模式分析桃園縣婦女的抹片檢查行為。衛生教育，1987；8：58-77。
葉季森：烏日鄉已婚婦女接受子宮頸抹片檢查影響因素研究。中臺學報，2002；13：1-12。
盧孳艷、阮月清：子宮頸抹片檢篩政策之身體政治。護理雜誌，2003；50(5)：10-15。
簡大任、季瑋珠：台北市有偶婦女接受子宮頸抹片檢查影響因素之探討。中華衛誌，1995；14(2)：111-127。
顏兆雄：子宮頸癌篩檢之新發展。當代醫學，2003；30(5)：371-376。
顏兆熊：子宮頸抹片異常的分類與處置。台灣醫界，2004；47(4)，12-14。

英文文獻
Abdullah AS, Leung TY. Factors associated with the use of breast and cervical cancer screening services among Chinese women in Hong Kong. Public Health 2001;115:212-217.
Abraído-Lanza AF, Chao MT, G. MD. Breast and cervical cancer screening among Latinas and non-Latina whites. Am J Public Health 2004;94(8):1393-1398.
Ballegooijen MJ, Marle ME, Patnick J, Lynge E, Arbyn M, Anttila A, Ronco G, Dik J, Habbema F. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000;36(17):2177-2188.
Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974;1(7865):1037-1040.
Bos AB, van Ballegooijen M, van Gessel-Dabekaussen AA, Habbema JD. Organised cervical cancer screening still leads to higher coverage than spontaneous screening in The Netherlands. Eur J Cancer 1998;34(10):1598-1601.
Boyes DA. The Value of Pap Smear Program and Suggestions for Its Implementation. Cancer 1978;48(2):613-621.
Byrd TL, Peterson SK, Chavez R, Heckert A. Cervical cancer screening beliefs among young Hispanic women. Prev Med 2004;38(2):192-197.
Chen TH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS, Tung TH, Huang CC, Chan CC, Shiu MN, Yeh YP, Liou HH, Liao CS, Lai HC, Chiang CP, Peng HL, Tseng CD, Yen MS, Hsu WC, Chen CH. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants, Taiwan Community-based Integrated Screening Group. Cancer 2004;100(8):1734-1743.
Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119(5):1095-1101.
Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362(9399):1871-1876.
Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer 2006;106:664-669.
Fey MC, Beal MW. Role of human papilloma virus testing in cervical cancer prevention. J Midwifery Womens Health 2004;49(1):4-13.
Hansen G. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer. Crit Rev Oncol Hematol 1999;32(2):133-144.
Hewitt M, Devesa S, Breen N. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth. Am J Public Health 2002;92(4):666-669.
Hiatt RA, Pasick RJ, Stewart S, Bloom J, Davis P, Gardiner P, Johnston M, Luce J, Schorr K, Brunner W, Stroud F. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med 2001;33(3):190-203.
Hoffman M, Pick WM, Cooper D, Myers JE. Women''s health status and use of health services in a rapidly growing peri-urban area of South Africa. Soc Sci Med 1997;45(1):149-157.
Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, Bowen D, Limacher M, Lillington L, Mason E. The Importance of Health Insurance as a Determinant of Cancer Screening: Evidence from the Women''s Health Initiative. Prev Med 2000;31(3):261-270.
Huang CP, Chi LY, Chang HJ, Chou P. Cognition and Utilization of Papanicolaou Testing after the Implementation of National Health Insurance in Rural Taiwan. J Formos Med Assoc 1999;98(1):19-23.
Johnston G, Orbell S, Crombie I, Robertson A, Kenicer M. Women’s preferences for cervical screening: who, where and when. Health Education Journal 1996;55:84-91.
Juon HS, Seung-Lee C, Klassen AC. Predictors of regular Pap smears among Korean-American women. Prev Med 2003;37:585-592.
Khanna N, Phillips MD. Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions. J Am Board Fam Pract 2001;14(2): 123-130.
Koong SL, Yen AM, Chen TH. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. J Med Screen 2006;13 Suppl 1:S44-7.
Koss LG. The papanicolaou test for cervical cancer detection, a triumph and a tragedy. JAMA 1989;261:737-743.
Lee MC. Knowledge, barriers, and motivators related to cervical cancer screening among Korean-American women. A focus group approach. Cancer Nurs 2000;23(3):168-175.
Leung GM, Woo PP, Cowling BJ, Tsang CS, Cheung AN, Ngan HY, Galbraith K, Lam TH. Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese? J Public Health (Oxf) 2008;30(3):282-92
Majeed FA, Cook DG, Anderson HR, Hilton S, Bunn S, Stones C. Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ 1994;308(6939):1272-1276.
Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health 2001;91(6): 947-952.
Marteau TM, Hankins M, Collins B. Perceptions of risk of cervical cancer and attitudes towards cervical screening: a comparison of smokers and non-smokers. Fam Pract 2002;19(1):18-22.
Maxwell AE, Bastani R, Warda US. Demographic predictors of cancer screening among Filipino and Korean immigrants in the United States. Am J Prev Med 2000;18(1):62-68.
Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL; Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357(16):1579-1588.
Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic Abnormalities: A systematic review. Ann Intern Med 2000;132(10):810-819.
Nguyen TT, McPhee SJ, Nguyen T, Lam T, Mock J. Predictors of cervical Pap smear screening awareness, intention, and receipt among Vietnamese-American women. Am J Prev Med 2002;23(3):207-214.
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118(12):3030-3044.
Patnick J. Cervical cancer screening in England. Eur J Cancer 2000;36(17):2205-2208.
Reid J. Women''s knowledge of Pap smears, risk factors for cervical cancer, and cervical cancer. J Obstet Gynecol Neonatal Nurs 2001;30(3):299-305.
Ronco G, Segnan N, P. A. Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes. Int J Epidemiol 1991;20(2):349-353.
Schenck U, von Karsa L. Cervical cancer screening in Germany. Eur J Cancer 2000;36(17):2221-2226.
Sherris J. Cervical cancer prevention: A strategic opportunity to improve women''s reproductive health. Internation Family Planning Perspectives 1999;25(6):56-57.
Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA 2004;291(24):2990-2993.
Sirovich BE, Woloshin S, Schwartz LM. Screening for cervical cancer: will women accept less? Am J Med 2005;118(2):151-158.
Somkin CP, McPhee SJ, Nguyen T, Stewart S, Shema SJ, Nguyen B, Pasick R. The Effect of Access and Satisfaction on Regular Mammogram and Papanicolaou Test Screening in a Multiethnic Population. Med Care 2004;42:914-926.
Taylor VM, Jackson JC, Tu SP, Yasui Y, Schwartz SM, Kuniyuki A, Acorda E, Lin K, Hislop G. Cervical cancer screening among Chinese Americans. Cancer Detect Prev 2002;26(2):139-145.
Vilos GA. Dr. George Papanicolaou and the birth of the Pap test. Obstet Gynecol Surv 1999;54(8):481-483.
Wang PD, Lin RS. Sociodemographic factors of Pap smear screening in Taiwan. Public Health 1996;110(2):123-127.
Zambrana RE, Breen N, Fox SA, Gutierrez-Mohamed ML. Use of cancer screening practices by Hispanic women: analyses by subgroup. Prev Med 1999;29(6):466-477.